Close search modal

About us

A New Paradigm of Cardiometabolic
Disease Prevention

Mediwhale is an AI-powered healthcare company dedicated to developing
preventive technologies that enable personalized disease management and early risk
detection of major chronic diseases

Our Mission

We believe that early detection is key to prevention.
Our mission is to empower everyone to detect health risks early through a simple eye scan in a primary care setting, making this approach easy, accessible, safe, and cost-effective.

Our Technology

Mediwhale leverages retinal imaging and AI to establish a new standard in early
detection, personalized risk assessment, and preventive care.
By transforming cardiometabolic disease prevention, retinal AI enables early
risk detection for proactive and preventive healthcare.

Why Retina?

The eye is more than a window to the soul—it’s a gateway to your overall health.

The retina’s intricate network of blood vessels mirrors systemic changes in the heart, brain, kidneys, and beyond.

Advanced retinal imaging not only provides a non-invasive, painless, and radiation-free method to assess vascular and metabolic health, but it also unlocks early markers of diseases like cardiovascular conditions and neurodegeneration—often before symptoms appear.

With the power of AI-driven analysis, retinal scans are revolutionizing personalized care, offering a glimpse into future health risks and enabling proactive, preventative treatment.

Core Strength

  • Clinically Proven and Powerful AI

    Build on over 2.1M high-quality clinical data points, Mediwhale’s AI is trained across diverse populations and imaging devices — enabling robust, generalizable performance. Proven through 50+ peer-reviewed publications, global clinical studies, and third-party validations.

  • Commercially Deployed and Globally Certified

    Mediwhale’s AI solution is fully deployed beyond pilot stage — certified in 8 regions and adopted by many hospitals and clinics worldwide, proving real-world scalability, operational value, and global credibility.

  • Designed to Fit Seamlessly into Real-world Healthcare

    Mediwhale’s AI solution provides a safe, radiation-free test completed in just minutes — ensuring maximum comfort for patients and instant, accurate results for doctors.

Our Roadmap

We are unlocking the potential of the retina to expand disease
prediction across multiple organ systems

Cardiovascular disease

Dr. Noon CVD : Retina-based AI solution that predicts the future risk of cardiovascular
disease risk

Chronic kidney disease

Dr. Noon CKD : Retina-based AI solution that predicts the future risk of chronic kidney
disease risk

Eye disease

Dr. Noon Fundus : Retina-based AI solution that diagnoses retinal abnormalities

Metabolic dysfunction associated steatotic liver disease

Research in progress

Cognitive disorder

Research in progress

Be Part of Mediwhale’s Journey in Revolutionizing Cardiometabolic Disease Prevention

Learn more about
Mediwhale’s AI solution